Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination

摘要：

On April 13,2021,the US Centers for Disease Control and Prevention(CDC)and the US Food and Drug Adminis-tration(FDA)recommended a pause in administration of the Ad26.COV2.S(Johnson&Johnson[Janssen])cor-onavirus disease 2019(COVID-19)vaccine for all persons[1].At that time,approximately 6.8 million doses of vaccine had been administered around the United States.

所属期刊栏目：15

在线出版日期：2022-02-16（万方平台首次上网日期，不代表论文的发表时间）

页数：共4页

页码：938-941